Trial Profile
Phase III clinical study of DR-3355 injection in patients with surgical infection.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 07 Jan 2022
Price :
$35
*
At a glance
- Drugs Levofloxacin (Primary)
- Indications Postoperative infections
- Focus Therapeutic Use
- Sponsors Daiichi Sankyo Company
- 09 Jun 2016 New trial record